Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Capital Reinvestment Ratio
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd capital reinvestment ratio. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Capital Reinvestment Ratio of 4.72x as of December 2024, meaning it reinvests 5% of its operating cash flow (CN¥5.11 Million) in capital expenditures (CN¥24.11 Million). Check how aggressively does Gansu Longshenrongfa Pharmaceutical Indu reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2024)
Capital reinvestment ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2024. This chart tracks Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Also explore 300534 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Capital Reinvestment Ratio by Year (2011–2024)
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see Gansu Longshenrongfa Pharmaceutical Indu operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.46x | CN¥170.14 Million | CN¥78.22 Million | ▼ -64.9% |
| 2023 | 1.31x | CN¥96.53 Million | CN¥126.36 Million | ▲ +9.8% |
| 2022 | 1.19x | CN¥11.43 Million | CN¥13.63 Million | ▲ +14639.1% |
| 2021 | 0.01x | CN¥51.13 Million | CN¥413.70K | ▼ -98.1% |
| 2020 | 0.43x | CN¥43.50 Million | CN¥18.55 Million | ▼ -57.8% |
| 2019 | 1.01x | CN¥28.21 Million | CN¥28.52 Million | ▲ +272.7% |
| 2018 | 0.27x | CN¥10.23 Million | CN¥2.78 Million | ▼ -93.3% |
| 2016 | 4.04x | CN¥13.14 Million | CN¥53.03 Million | ▼ -25.0% |
| 2015 | 5.38x | CN¥30.60 Million | CN¥164.66 Million | ▲ +111.3% |
| 2014 | 2.55x | CN¥39.01 Million | CN¥99.35 Million | ▲ +50.1% |
| 2013 | 1.70x | CN¥35.92 Million | CN¥60.94 Million | ▲ +150.2% |
| 2012 | 0.68x | CN¥35.62 Million | CN¥24.15 Million | ▼ -43.6% |
| 2011 | 1.20x | CN¥10.16 Million | CN¥12.21 Million | — |